INSM

2026Q2BMO

Insmed Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-08-06 · Fiscal end 2026-06-30 · Features as of 2026-08-05

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-0.69
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.6%
IV front—
P/C full—
P/C front—
Features as of2026-08-05

Run-up

Close—
Ret 5d-4.0%
Ret 10d-7.1%
Ret 20d-15.0%
Ret 30d-3.1%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-0.52Beat
Estimated EPS-0.69
Actual revenue
425.5M
Surprise %+24.6%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction+3.4%
Implied vs actual

Implied 4.6%Actual 29.5%

Gap reaction+29.5%
Day result+33.9%
Next-day upYes
Realized / IV6.38×

Post tape

Post 5d-4.7%
Post 10d-5.6%
Post volume12.0M
Vol ×10d4.19×
Vol ×20d4.58×
Post range9.0%